London, UK and Melbourne, Australia, 30 October 2017 – Leading healthcare investment specialist BioScience Managers Limited (BioScience Managers), has announced the expansion of its team with the addition of three new directors with broad sector and geographic experience – Dr Michael Perry as a Director, Dennis Purcell as a Director and Senior Expert Advisor, and […]
BioScience Managers commits AUS$10M to new joint venture with Canary Medical to serve as a platform to collect and monetize data from implantable and wearable medical devices. Vancouver, British Columbia, Aug 1, 2017 – Canary Medical (Canary) is pleased to announce the formation of CHARM Informatics Pty Ltd (CHARM), in collaboration with BioScience Managers Pty Ltd […]
BioScience Managers Appoints Elizabeth Klein as Investment Consultant in the UK to Support Bioscience Managers’ and Downing’s Life Sciences Investments London, UK and Melbourne, Australia, 31 July 2017 – Leading healthcare investment specialist BioScience Managers Limited (BioScience Managers) announces today that it has appointed Elizabeth Klein as an Investment Consultant, to facilitate BioScience Managers’ UK […]
13 December 2016 Joint media release with the Hon. Sussan Ley MP, Minister for Health and Aged Care. The Turnbull Government is today launching the $500 million Biomedical Translation Fund, established under the government’s National Innovation and Science Agenda, which will help take Australian biomedical discoveries out of the laboratory and to the patient. Three […]
Melbourne, Australia 13 December, 2016 – BioScience Managers, one of Australia’s leading life sciences investment firms, has been awarded a $100 million investment licence for the Federal Government-backed Biomedical Translation Fund. BioScience Managers is one of three fund managers chosen to invest on behalf of the BTF and will be responsible for $100 million, half from […]
Agreement with Downing to launch a new Healthcare Offer for VCT investors A target raise of £10 million with investors able to make monthly contributions High demand likely, with fewer offers open to investment Portfolio to target dividends of at least 4 per cent pa (of net assets) from the fourth year onwards Melbourne, Australia […]
Sarah-Jane Tasker – The Australian October 13, 2016 BioScience Managers is a small step away from running a $150 million fund under the government’s Biomedical Translation Fund, a move it says will revitalise the biotech sector. Jeremy Curnock-Cook, the managing director of Melbourne-based BioScience Managers, said the translation fund was an important initiative as it […]
Melbourne, Australia, 3 October, 2016 – Australia’s innovative healthcare and biomedical research sectors are set for a massive boost with the launch of a new venture capital fund. “This is a breakthrough moment for many earlier stage, unlisted companies,” said BioScience Managers’ managing director Jeremy Curnock Cook. “Access to funding is vital in turning ideas […]
Jeremy Curnock Cook on Sky News Business (The Perrett Report) Oct 27, 2015. Additionally it can be downloaded here: https://www.hightail.com/download/bXBZZUNxeFhRWUlsYzlVag
Potential breakthrough treatment for chronic pain Part of $10m capital raising BioScience Managers achieved a 24.7% IRR in its previous fund – top decile performance of international private equity and venture capital fund managers. 20 February 2015, Melbourne, Australia: Leading healthcare fund manager BioScience Managers has invested $5 million in novel chronic pain treatment company Saluda […]